Ortigosa, L.C. et al. 2013. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis. Acta Dermato-Venereologica. 94, 1 (Jul. 2013), 26–31. DOI:https://doi.org/10.2340/00015555-1650.